FDA/EMA Review Discord: Is Europe Slow On Oncology, Or Just Fast On Everything Else?
This article was originally published in The Pink Sheet Daily
Executive Summary
Tufts study finds that FDA approves oncology drugs in seven months and non-oncology drugs in 17 months; European Medicines Agency approval times are 27% shorter for non-oncology drugs and 54% longer for oncology therapeutics compared to FDA.